Evidence map›Paper›PMID 28216065›Full record

Trial reportLung cancer (Amsterdam, Netherlands)2017

Preliminary evaluation of a telephone-based smoking cessation intervention in the lung cancer screening setting: A randomized clinical trial.

Kathryn L Taylor, Charlotte J Hagerman, George Luta, Paula G Bellini, Cassandra Stanton, David B Abrams, Jenna A Kramer, Eric Anderson, Shawn Regis, Andrea McKee and 4 more

Registry-linked trialAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Lung cancer (Amsterdam, Netherlands), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02267096 (Lombardi Comprehensive Cancer Center/Legacy Pilot Study to Reduce Adverse Smoking Outcomes in the Context of Lung Cancer Screening), which is not on this map. Cited by 28 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 4 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02267096 phase3completednot on this map

Lombardi Comprehensive Cancer Center/Legacy Pilot Study to Reduce Adverse Smoking Outcomes in the Context of Lung Cancer Screening

TypeinterventionalSponsorGeorgetown UniversityRan2014 to 2016Enrolled95ConditionsSmoking, Lung CancerArmsTelephone Counseling, Minimal Treatment
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 4 syntheses or guidelines pooled it, 55 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Effect of a Personalized Tobacco Treatment Intervention on Smoking Abstinence in Individuals Eligible for Lung Cancer Screening.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2024
    Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Lung cancer screening and smoking cessation efforts.Translational lung cancer research · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 1 country.

Kathryn L TaylorLombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, United States. Electronic address: TAYLORKL@georgetown.edu.
Charlotte J HagermanLombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, United States.
George LutaDepartment of Biostatistics, Bioinformatics, and Biomathematics, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, United States.
Paula G BelliniLombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, United States.
Cassandra StantonLombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, United States; Behavioral Health Group, Westat, Inc., Rockville, MD, United States.
David B AbramsLombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, United States; The Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC, United States.
Jenna A KramerMedstar Georgetown University Hospital, Washington, DC, United States.
Eric AndersonMedstar Georgetown University Hospital, Washington, DC, United States.
Shawn RegisSophia Gordon Cancer Center, Lahey Hospital and Medical Center, Burlington, MA, United States.
Andrea McKeeSophia Gordon Cancer Center, Lahey Hospital and Medical Center, Burlington, MA, United States.
Brady McKeeSophia Gordon Cancer Center, Lahey Hospital and Medical Center, Burlington, MA, United States.
Ray NiauraLombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, United States; The Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC, United States.
Harry HarperJohn Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, United States.
Michael RamsaierJohn Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, United States.
Georgetown University · USLahey Medical Center · USGeorgetown University Medical Center · USHackensack University Medical Center · USMedStar Georgetown University Hospital · USWestat (United States) · US

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI MARCUS S NOEL · 1990 to 2026
$71.5M
NCI NIH HHS P30 CA051008
6 · The paper itself

Abstract

Incorporating effective smoking cessation interventions into lung cancer screening (LCS) programs will be essential to realizing the full benefit of screening. We conducted a pilot randomized trial to determine the feasibility and efficacy of a telephone-counseling (TC) smoking cessation intervention vs. usual care (UC) in the LCS setting. In collaboration with 3 geographically diverse LCS programs, we enrolled current smokers (61.5% participation rate) who were: registered to undergo LCS, 50-77 years old, and had a 20+ pack-year smoking history. Eligibility was not based on readiness to quit. Participants completed pre-LCS (T0) and post-LCS (T1) telephone assessments, were randomized to TC (N=46) vs. UC (N=46), and completed a final 3-month telephone assessment (T2). Both study arms received a list of evidence-based cessation resources. TC participants also received up to 6 brief counseling calls with a trained cessation counselor. Counseling calls incorporated motivational interviewing and utilized the screening result as a motivator for quitting. The outcome was biochemically verified 7-day point prevalence cessation at 3-months post-randomization. Participants (56.5% female) were 60.2 (SD=5.4) years old and reported 47.1 (SD=22.2) pack years; 30% were ready to stop smoking in the next 30 days. TC participants completed an average of 4.4 (SD=2.3) sessions. Using intent-to-treat analyses, biochemically verified quit rates were 17.4% (TC) vs. 4.3% (UC), p<.05. This study provides preliminary evidence that telephone-based cessation counseling is feasible and efficacious in the LCS setting. As millions of current smokers are now eligible for lung cancer screening, this setting represents an important opportunity to exert a large public health impact on cessation among smokers who are at very high risk for multiple tobacco-related diseases. If this evidence-based, brief, and scalable intervention is replicated, TC could help to improve the overall cost-effectiveness of LCS.

trial registrationNCT02267096, https://clinicaltrials.gov.

Indexed as

CounselingSmoking CessationTelephoneAgedEarly Detection of CancerEarly Intervention, EducationalFemaleHumansLung NeoplasmsMaleMass ScreeningMiddle AgedOutcome Assessment, Health CareTime FactorsLung cancer screeningRandomized trialSmoking cessationTelephone counseling

Identifiers

PMID28216065
PMCPMC5476481
OpenAlexW2588103044

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.